How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?
- Julie R. Gralow
- , Allan Lipton
- , Alison T. Stopeck
Research output: Contribution to journal › Letter › peer-review
2
Link opens in a new tab
Scopus
citations